Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10,876,096
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
540,753
-
Shares change
-
+540,643
-
Total reported value, excl. options
-
$1,211,630
-
Value change
-
+$1,211,205
-
Number of buys
-
17
-
Price
-
$2.24
Institutional Holders of AYTU BIOPHARMA, INC - Common Stock (AYTU) as of Q1 2023
As of 31 Mar 2023 AYTU BIOPHARMA, INC - Common Stock (AYTU) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 540,753 shares of stock of the company.
Largest 10 holders included Nantahala Capital Management, LLC, Alyeska Investment Group, L.P., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, COMMONWEALTH EQUITY SERVICES, LLC, PRUDENTIAL FINANCIAL INC, GEODE CAPITAL MANAGEMENT, LLC, and UBS Group AG.
This table shows 18 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.